ArticleJournal of cosmetic dermatology2025
Risk Factors of Acne Recurrence After Treatment and Establishment of an Early Warning Model.
Article in Journal of cosmetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Clinical Evaluation Indicators and Efficacy Assessment Methods in Acne: A Narrative Review.Journal of inflammation research · 2026Review
- Narrative nursing to address negative emotions, body image disturbance, and satisfaction in patients after axillary odor surgery: a sequential explanatory mixed-methods study.Frontiers in medicine · 2026Article
- Risk Factors of Acne Recurrence After Treatment and Establishment of an Early Warning Model.Journal of cosmetic dermatology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcne vulgaris is a chronic inflammatory disease of the pilosebaceous units. It primarily manifests as comedones, papules, pustules, nodules, and cysts, making it the most common inflammatory skin disorder involving hair follicles and sebaceous glands. Acne predominantly occurs in adolescents and young adults. With continuous social development and increasing aesthetic standards, the demand for effective acne management has grown. However, as acne treatment is often prolonged and challenging, most patients experience recurrence after therapy, which significantly impacts their daily lives and emotional well-being.
aimThis study aims to identify the factors associated with acne recurrence after treatment, and based on these findings, develop an early warning model to guide the prevention of acne recurrence.
methodsClinical data from 218 patients were retrospectively analyzed. Among them, 105 cases (48.17%) experienced acne recurrence; 49 cases (46.67%) had mild recurrence; 37 cases (35.24%) had moderate recurrence; 19 cases (18.10%) had severe recurrence. Logistic regression analysis revealed that body mass index (BMI), smoking history, alcohol consumption, Self-Rating Depression Scale (SDS) score, Self-Rating Anxiety Scale (SAS) score, staying up late, poor eating habits, and prolonged use of electronic devices were risk factors for recurrence. In contrast, weekly pillowcase replacement was identified as a protective factor.
resultsThe predictive model was formulated as follows: 0.516 + (BMI × 0.283) + (smoking history × 0.775) + (drinking history × 0.854) + (SDS × 0.842) + (SAS × 0.744) + (staying up late × 0.396) + (eating habits × 0.935) + (time using electronic devices × 0.832) + (weekly pillowcase replacement × -0.512). The sensitivity, specificity, and AUC (95% CI) of the model were 88.57%, 80.53%, and 0.846 (0.791-0.891), respectively.
conclusionThe early warning model based on recurrence risk factors demonstrated strong predictive performance and may serve as a valuable tool in the clinical prevention of acne recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.